Alnylam accuses Pfizer, Moderna of infringing a second patent

Alnylam is adding more fuel to the fire in its infringement lawsuits against Pfizer and Moderna, claiming both companies violated a patent that was just granted to the company on Tuesday. The fight is over mRNA technology Pfizer and Moderna used in developing their respective COVID-19 vaccines, Alnylam says. Alnylam originally filed lawsuits against each in March. On Tuesday in lawsuits filed in U.S. district court in Delaware, Alnylam said that its newly granted patent covers a specific class of lipid nanoparticles (LNPs) and how they are manufactured. LPLs deliver genetic material into cells.